MedTrace Logo

Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial

NCT00343902 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-06-23

No results posted yet for this study

Summary

To determine the effect of hawthorn extract 450 mg bid vs. placebo, in addition to standard medical therapy in ambulatory patients with NYHA class II to IV chronic heart failure on submaximal exercise as measured by the 6-minute walk test

Conditions

Interventions

DRUG

Crataegus Special Extract WS 1442

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • Keith D Aaronson, MD, MS · University of Michigan

  • Suzanna M Zick, ND, MPH · University of Michigan

  • Stephen Bolling, MD · University of Michigan, Department of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Completion
2004-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00343902 on ClinicalTrials.gov